 |
Articles: Renal/Urologic |
Prior Articles
Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators
European Journal of Cancer Care, 09/08/09
Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma
Journal of Clinical Oncology, 09/04/09 Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers
Journal of Clinical Oncology, 09/04/09 Cyclin D1 Splice Variants: Polymorphism, Risk, and Isoform-Specific Regulation in Prostate Cancer
Clinical Cancer Research, 09/04/09 Functional Significance of Secreted Frizzled-Related Protein 1 in Metastatic Renal Cell Carcinomas
Cancer Research, 09/03/09 A phase I/II study of gti-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: a study of the PMH Phase II Consortium
Journal of Thoracic Oncology, 09/02/09 Maximum vs. Mono Androgen Blockade and the Risk of Recurrence in Men With Localized Prostate Cancer Undergoing Brachytherapy
International Journal of Radiation Oncology*Biology*Physics, 09/02/09 Dose–Volume Relationships for Acute Bowel Toxicity in Patients Treated With Pelvic Nodal Irradiation for Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics, 09/02/09 Dosimetric Changes Resulting From Patient Rotational Setup Errors in Proton Therapy Prostate Plans
International Journal of Radiation Oncology*Biology*Physics, 09/02/09 Potential for Higher Treatment Failure in Obese Patients: Correlation of Elevated Body Mass Index and Increased Daily Prostate Deviations From the Radiation Beam Isocenters in an Analysis of 1,465 Computed Tomographic Images
International Journal of Radiation Oncology*Biology*Physics, 09/02/09 Inferences About Prostate Intrafraction Motion From Pre- and Posttreatment Volumetric Imaging
International Journal of Radiation Oncology*Biology*Physics, 09/02/09 Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)
Cancer, 09/01/09 Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death
International Journal of Radiation Oncology*Biology*Physics, 09/01/09 Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma
Journal of Clinical Oncology, 09/01/09 Final Results of Sequential Doxorubicin Plus Gemcitabine and Ifosfamide, Paclitaxel, and Cisplatin Chemotherapy in Patients With Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium
Journal of Clinical Oncology, 09/01/09 Molecular Characterization of Preneoplastic Lesions Provides Insight on the Development of Renal Tumors
American Journal of Pathology, 09/01/09 Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer
Journal of Clinical Oncology, 09/01/09 Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
Journal of Clinical Oncology, 09/01/09 Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer
Journal of Clinical Oncology, 09/01/09 Contemporary Risk Profile of Prostate Cancer in the United States
Journal of the National Cancer Institute, 08/31/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
